Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research

Collaboration will apply Aignostics' AI-technology to PanCAN's multimodal pancreatic cancer dataset, with results made broadly accessible to both academic and life sciences researchers. LOS ANGELES and BERLIN and NEW YORK, June 9, 2026 /PRNewswire/ -- Today, Aignostics announced a new...